Literature DB >> 9287940

Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland.

T U Kosunen1, A Aromaa, P Knekt, A Salomaa, H Rautelin, P Lohi, O P Heinonen.   

Abstract

Changes in Helicobacter pylori seroprevalence were studied determining IgG and IgA antibodies of 408 randomly selected adults aged 15-74 years living in Vammala, Finland in 1973 and of 504 similarly selected subjects in 1994. Seroprevalence increased by age at both time points. The age-adjusted seroprevalence rate was clearly lower in 1994 than in 1973 (31 vs. 56%, P = 0.001). Paired serum samples of 224 subjects collected in 1973 and 1994 showed that the antibody status remained unaltered in 92%; 4% seroconverted and 4% seroreverted within the 21 years. The decrease in the seroprevalence rate in the population and the persistence of individual antibody status over two decades support a difference in H. pylori infection rates among birth cohorts over time rather than continuous acquisition of new infections with advancing age. Thus the risk of helicobacter infection in Vammala, Finland has been highest in childhood and continuously decreased at least for the last five decades.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287940      PMCID: PMC2808819          DOI: 10.1017/s0950268897007565

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  35 in total

Review 1.  Helicobacter pylori genetic diversity and risk of human disease.

Authors:  M J Blaser; D E Berg
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Helicobacter pylori-reflections for the next millennium.

Authors:  G N Tytgat
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  Does Helicobacter pylori protect against asthma and allergy?

Authors:  Martin J Blaser; Yu Chen; Joan Reibman
Journal:  Gut       Date:  2008-01-14       Impact factor: 23.059

4.  Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community.

Authors:  Lars Agréus; Per M Hellström; Nicholas J Talley; Bengt Wallner; Anna Forsberg; Michael Vieth; Lothar Veits; Karin Björkegren; Lars Engstrand; Anna Andreasson
Journal:  United European Gastroenterol J       Date:  2015-12-18       Impact factor: 4.623

5.  Non-Invasive Diagnosis of Helicobacter pylori: Evaluation of Two Enzyme Immunoassays, Testing Serum IgG and IgA Response in the Anand District of Central Gujarat,India.

Authors:  Himani Bhardwaj Pandya; Jagdish Shantilal Patel; Harihar Hardas Agravat; Navneet Kumar Ramdayal Singh
Journal:  J Clin Diagn Res       Date:  2014-06-20

6.  Helicobacter pylori infection in pregnant women from a U.S.-Mexico border population.

Authors:  Karen J Goodman; Kathleen O'Rourke; R Sue Day; Constance Wang; Thomas Redlinger; Armando Campos; Jose Manuel de la Rosa
Journal:  J Immigr Health       Date:  2003-07

7.  Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Authors:  Lea Veijola; Aino Oksanen; Pentti Sipponen; Hilpi Rautelin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

8.  High prevalence of gastroesophageal reflux symptoms in patients with both acute and nonacute cough.

Authors:  Yoshihisa Urita; Toshiyasu Watanabe; Hiroki Ota; Motohide Iwata; Yosuke Sasaki; Tadashi Maeda; Takamasa Ishii; Makie Nanami; Asuka Nakayama; Hirohito Kato; Kazuo Hike; Noriko Hara; Masaki Sanaka; Yoko Nagai; Shuji Watanabe; Kazushige Nakanishi; Hitoshi Nakajima; Motonobu Sugimoto
Journal:  Int J Gen Med       Date:  2008-11-30

9.  Significant decrease in prevalence of Helicobacter pylori in the Czech Republic.

Authors:  Jan Bureš; Marcela Kopáčová; Ilona Koupil; Bohumil Seifert; Miluška Skodová Fendrichová; Jana Spirková; Viktor Voříšek; Stanislav Rejchrt; Tomáš Douda; Norbert Král; Ilja Tachecí
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

10.  Asthma is inversely associated with Helicobacter pylori status in an urban population.

Authors:  Joan Reibman; Michael Marmor; Joshua Filner; Maria-Elena Fernandez-Beros; Linda Rogers; Guillermo I Perez-Perez; Martin J Blaser
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.